Skip to main content

Mechanismen der Thrombozytenhemmung durch PETN

  • Chapter
Pentaerithrityltetranitrat

Zusammenfassung

Die vasodilatierende Wirkung organischer Nitratester ist experimentell und klinisch gut belegt [1,19]. Für verschiedene Nitrate ist aber auch eine thrombozytenhemmende Wirkung nachgewiesen worden [3–5, 8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahlner J, Anderson RGG, Tofgard K, Axelsson KL (1991) Organic nitrate esters: clinical use and mechanisms of action. Pharmacol Rev 43: 351

    PubMed  CAS  Google Scholar 

  2. BrüneB, Ullrich V (1987) Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32: 497

    Google Scholar 

  3. De Catering R, Giannessi D, Bernini W, Mazzone A (1988) Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Thromb Haemost 59: 207

    Google Scholar 

  4. Gerzer R, Karrenbrock B, Siess W, Heim J-M (1988) Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res 52: 11

    Article  PubMed  CAS  Google Scholar 

  5. Karlberg K-E, Tofgard K, Ahlner J, Sylvén C (1992) Dose-dependent effect of intravenous nitroglycerin on platelet aggregation and correlation with plasma glyceryl dinitrate concentration in healthy men. Am J Cardiol 69: 802

    Article  PubMed  CAS  Google Scholar 

  6. Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E (1995) In vivo effects of pentaerithrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits. J Cardiovasc Pharmacol 25: 763

    Article  PubMed  CAS  Google Scholar 

  7. Kuhn M, Otten A, Fröhlich JC, Förstermann U (1991) Glyceryl trinitrate increases platelet cGMP after metabolism in fibroblasts. Eur J Pharmacol 200: 175

    Article  PubMed  CAS  Google Scholar 

  8. Loscalzo J (1985) N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 76: 703

    Article  PubMed  CAS  Google Scholar 

  9. Maurice DH, Haslam RJ (1990) Molecular basis of the synergistic inhibition of platelet function by nitro-vasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37: 671

    PubMed  CAS  Google Scholar 

  10. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3’, 5’-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946

    PubMed  CAS  Google Scholar 

  11. Negrescu EV, Sazonova LN, Baldenkov GN, Mukharliamov NM, Mazaev AV, Tkachuk VA (1990) Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. Int J Cardiol 26: 175

    Article  PubMed  CAS  Google Scholar 

  12. Nishikawa M, Kanamori M, Hidaka H (1982) Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and is metabolites. J Pharmacol Exp Ther 220: 183

    PubMed  CAS  Google Scholar 

  13. Noack E, Kojda G (1994) Pentaerithrityltetranitrat. Gesichertes und Neues zur Pharmakologie eines Langzeitnitrats. Steinkopff-Verlag, Darmstadt

    Google Scholar 

  14. Salvemini D, Radziszewski R, Korbut R, Vane J (1990) The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO- donors. Br J Pharmacol 101: 991

    PubMed  CAS  Google Scholar 

  15. Schrör K, Franta M, Weber A-A (1995) Wirkung von PETN auf Plättchenfunktion und cGMP-Bildung in Humanthrombozyten. In: Haustein K-O (Hrsg) Pentaerithrityltetranitrat. Pharmakologische Besonderheiten für Praxis und Klinik. Steinkopf Verlag, Darmstadt, p 5

    Google Scholar 

  16. Weber A-A, Strobach H, Schrör K (1993) Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 247: 29

    Article  PubMed  CAS  Google Scholar 

  17. Weber A-A, Franta M, Neuhaus T, Sachinidis A, Schrör K (1996) Effects of pentaerythritol tetranitrate on platelet function. Naunyn-Schmied Arch Pharmacol 353 (Suppl): R39

    Google Scholar 

  18. Weber A-A, Neuhaus T, Düsing R, Schrör K, Sachinidis A, Vetter H (1996) Biotransformation von Nitroglyzerin und Nitrattoleranz in gewaschenen Human-thrombozyten. Z Kardiol (im Druck)

    Google Scholar 

  19. Yusuf S, MacMahon S, Collins R, Peto R (1988) Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomized trials. Lancet 1: 1088

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Dr. Dietrich Steinkopff Verlag, Darmstadt

About this chapter

Cite this chapter

Weber, AA., Schrör, K. (1996). Mechanismen der Thrombozytenhemmung durch PETN. In: Mutschler, E., Stalleicken, D., Schneider, H.T. (eds) Pentaerithrityltetranitrat. Steinkopff. https://doi.org/10.1007/978-3-642-85438-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85438-5_4

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1070-8

  • Online ISBN: 978-3-642-85438-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics